Weight Gain is Not Associated with Antipsychotic Medication, Sociodemographic Factors, or Diagnosis in a Welsh Secure Mental Health Unit

References

• Benton, D., & Young, H. (2016). A meta-analysis of the relationship between brain dopamine receptors and obesity: A matter of changes in behavior rather than food addiction? International Journal of Obesity, 40(S1), S12–S21. https://doi.org/10.1038/ijo.2016.9
   Google Scholar
• Blum, K., Thanos, P., & Gold, M. (2014). Dopamine and glucose, obesity, and reward deficiency syndrome. Frontiers in Psychology, 5, Article 919. https://doi.org/10.3389/fpsyg.2014.00919
   PubMed Web of Science ®Google Scholar
• Carter, A., Hendrikse, J., Lee, N., Yücel, M., Verdejo-Garcia, A., Andrews, Z., & Hall, W. (2016). The neurobiology of “food Addiction” and its implications for obesity treatment and policy. Annual Review of Nutrition, 36(1), 105–128. https://doi.org/10.1146/annurev-nutr-071715-050909
   PubMedGoogle Scholar
• Davies, J. L., Bagshaw, R., Watt, A., Hewlett, P., & Seage, H. (2023). Staff perspectives on obesity within a Welsh secure psychiatric inpatient setting. The Journal of Mental Health Training, Education and Practice, 18(1), 44–52. https://doi.org/10.1108/JMHTEP-06-2022-0050
   Web of Science ®Google Scholar
• Day, M., & Johnson, M. (2017). Working together to address obesity in adult mental health secure units: A systematic review of the evidence and a summary of the implications for practice (Cm 2016614). Public Health England.
   Google Scholar
• De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2011). Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nature Reviews. Endocrinology, 8(2), 114–126. https://doi.org/10.1038/nrendo.2011.156
   PubMed Web of Science ®Google Scholar
• De Leon, J., Diaz, F. J., Josiassen, R. C., Cooper, T. B., & Simpson, G. M. (2007). Weight gain during a double-blind multidosage clozapine study. Journal of Clinical Psychopharmacology, 27(1), 22–27. https://doi.org/10.1097/JCP.0b013e31802e513a
   PubMed Web of Science ®Google Scholar
• Eagle, K., Ma, T., & Sinclair, B. (2019). Integrated substance use rehabilitation in a secure forensic facility. Journal of Forensic Practice, 21(1), 50–60. https://doi.org/10.1108/JFP-09-2018-0037
   Web of Science ®Google Scholar
• Engelke, C., Lange-Asschenfeldt, C., Peter, S., Kahl, K. G., Frasch, K., Larsen, J. I., Bickel, G. G., Bork, B., Jacobsen, B. A., Wallenstein-Jensen, S. O., Lauber, C., Mogensen, B., Nielsen, J. A., Rössler, W., Tsuchiya, K. J., Toftegaard, K. L., Andersen, U. A., Uwakwe, R., Munk-Jørgensen, P., & Cordes, J. (2018). A cross-continental analysis of weight gain, psychiatric diagnoses and medication use during inpatient psychiatric treatment. the international study on physical illness in mentally ill. European Psychiatry : The Journal of the Association of European Psychiatrists, 48(1), 65–70. https://doi.org/10.1016/j.eurpsy.2017.11.004
   PubMedGoogle Scholar
• Ethridge, L. E., Soilleux, M., Nakonezny, P. A., Reilly, J. L., Kristian Hill, S., Keefe, R. S. E., Gershon, E. S., Pearlson, G. D., Tamminga, C. A., Keshavan, M. S., & Sweeney, J. A. (2014). Behavioral response inhibition in psychotic disorders: Diagnostic specificity, familiarity and relation to generalized cognitive deficit. Schizophrenia Research, 159(2-3), 491–498. https://doi.org/10.1016/j.schres.2014.08.025
   PubMed Web of Science ®Google Scholar
• Every-Palmer, S., Huthwaite, M. A., Elmslie, J. L., Grant, E., & Romans, S. E. (2018). Long-term psychiatric inpatients’ perspectives on weight gain, body satisfaction, diet and physical activity: A mixed methods study. BMC Psychiatry, 18(1), 300. https://doi.org/10.1186/s12888-018-1878-5
   PubMedGoogle Scholar
• Farrell, C., & Brink, J. (2020). The prevalence and factors associated with antipsychotic polypharmacy in a forensic psychiatric sample. Frontiers in Psychiatry, 11, Article 263. https://doi.org/10.3389/fpsyt.2020.00263
   Web of Science ®Google Scholar
• Foley, D. L., & Morley, K. I. (2011). Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Archives of General Psychiatry, 68(6), 609–616. https://doi.org/10.1001/archgenpsychiatry.2011.2
   PubMed Web of Science ®Google Scholar
• Grootens, K. P., Meijer, A., Hartong, E. G., Doornbos, B., Roberto Bakker, P., Al Hadithy, A., Hoogerheide, K. N., Overmeire, F., Marijnissen, R. M., & Ruhe, H. G. (2018). Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder Koen. European Journal of Clinical Pharmacology, 74(11), 1491–1491. https://doi.org/10.1007/s00228-018-2556-8
   PubMed Web of Science ®Google Scholar
• Harvey, P. D., & Strassnig, M. T. (2019). Cognition and disability in schizophrenia: Cognition-related skills deficits and decision-making challenges add to morbidity. World Psychiatry : Official Journal of the World Psychiatric Association (WPA), 18(2), 165–167. https://doi.org/10.1002/wps.20647
   PubMed Web of Science ®Google Scholar
• Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005). Schizophrenia and 228 increased risks of cardiovascular disease. American Heart Journal, 150(6), 1115–1121. https://doi.org/10.1016/j.ahj.2005.02.007
   PubMed Web of Science ®Google Scholar
• Hilton, N. Z., Ham, E., Hill, S., Emmanuel, T., & Thege, B. K. (2022). Predictors of weight gain and metabolic indexes among men admitted to forensic psychiatric hospital. International Journal of Forensic Mental Health, 21(2), 164–174. https://doi.org/10.1080/14999013.2021.1952356
   Web of Science ®Google Scholar
• Hilton, N. Z., Ham, E., Lang, C., & Harris, G. T. (2015). Weight gain and its correlates among forensic inpatients. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 60(5), 232–238. https://doi.org/10.1177/070674371506000505
   PubMed Web of Science ®Google Scholar
• Hodgkins, C. C., Cahill, K. S., Seraphine, A. E., Frost-Pineda, K., & Gold, M. S. (2004). Adolescent drug addiction treatment and weight gain. Journal of Addictive Diseases, 23(3), 55–65. https://doi.org/10.1300/J069v23n03
   PubMed Web of Science ®Google Scholar
• Hjorthøj, C., Stürup, A. E., McGrath, J. J., & Nordentoft, M. (2017). Years of potential life lost and life expectancy in schizophrenia: A systematic review and meta-analysis. The Lancet. Psychiatry, 4(4), 295–301. https://doi.org/10.1016/S2215-0366(17)30078-0
   PubMed Web of Science ®Google Scholar
• Huthwaite, M., Elmslie, J., Every-Palmer, S., Grant, E., & Romans, S. E. (2017). Obesity in a forensic and rehabilitation psychiatric service: A missed opportunity? Journal of Forensic Practice, 19(4), 269–277. https://doi.org/10.1108/JFP-03-2017-0007
   Web of Science ®Google Scholar
• IBM Corp. (2019). IBM SPSS Statistics for Windows (Version 26.0) [Computer software].
   Google Scholar
• Jakobsen, K., Frederiksen, J., Hansen, T., Jansson, L., Parnas, J., & Werge, T. (2005). Reliability of clinical ICD-10 schizophrenia diagnoses. Nordic Journal of Psychiatry, 59(3), 209–212. https://doi.org/10.1080/08039480510027698
   PubMed Web of Science ®Google Scholar
• Johnson, M., Day, M., Moholkar, R., Gilluley, P., & Goyder, E. (2018). Tackling obesity in mental health secure units: a mixed method synthesis of available evidence. BJPsych Open, 4(4), 294–301. https://doi.org/10.1192/bjo.2018.26
   PubMed Web of Science ®Google Scholar
• Kelly, N. R., Jaramillo, M., Ramirez, S., Altman, D. R., Rubin, S. G., Yang, S. B., Courville, A. B., Shank, L. M., Byrne, M. E., Lemay‐Russell, S., Brady, S. M., Broadney, M. M., Tanofsky‐Kraff, M., & Yanovski, J. A. (2020). Executive functioning and disinhibited eating in children and adolescents. Pediatric Obesity, 15(6), 1–10. https://doi.org/10.1111/ijpo.12614
   Web of Science ®Google Scholar
• Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: A neurocircuitry analysis. The Lancet. Psychiatry, 3(8), 760–773. https://doi.org/10.1016/S2215-0366(16)00104-8
   PubMed Web of Science ®Google Scholar
• Kyle, T., & Kuehl, B. (2020). Prescription medications & weight gain: What you need to know. Obesity Action. https://www.obesityaction.org/wp-content/uploads/prescription_medications.pdf
   Google Scholar
• Laursen, T. M., Munk-Olsen, T., & Vestergaard, M. (2012). Life expectancy and cardiovascular mortality in persons with schizophrenia. Current Opinion in Psychiatry, 25(2), 83–88. https://doi.org/10.1097/YCO.0b013e32835035ca
   PubMed Web of Science ®Google Scholar
• Lavagnino, L., Arnone, D., Cao, B., Soares, J. C., & Selvaraj, S. (2016). Inhibitory control in obesity and binge eating disorder: A systematic review and meta-analysis of neurocognitive and neuroimaging studies. Neuroscience and Biobehavioral Reviews, 68, 714–726. https://doi.org/10.1016/j.neubiorev.2016.06.041
   PubMed Web of Science ®Google Scholar
• Levitt, G. A., Shinault, K., Patterson, S., & Otaluka, O. (2017). Weight gain in psychiatric inpatients: Are interventions making a positive impact? The Primary Care Companion for CNS Disorders, 19(04) https://doi.org/10.4088/PCC.17m02111
   PubMedGoogle Scholar
• Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., Kissling, W., Stapf, M. P., Lässig, B., Salanti, G., & Davis, J. M. (2013). Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis. Lancet (London, England), 382(9896), 951–962. https://doi.org/10.1016/S0140-6736(13)60733-3
   PubMed Web of Science ®Google Scholar
• Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. Lancet (London, England), 373(9657), 31–41. https://doi.org/10.1016/S0140-6736(08)61764-X
   PubMed Web of Science ®Google Scholar
• Li, Y., Yu, Y., Wu, Y., Liang, W., Dong, B., Xue, R., Dong, Y., Zhu, W., & Huang, P. (2021). Association of body-weight fluctuation with outcomes in heart failure with preserved ejection fraction. Frontiers in Cardiovascular Medicine, 8, Article 689591. https://doi.org/10.3389/fcvm.2021.689591
   Web of Science ®Google Scholar
• Litwin, R., Goldbacher, E. M., Cardaciotto, L. A., & Gambrel, L. E. (2017). Negative emotions and emotional eating: the mediating role of experiential avoidance. Eating and Weight Disorders, 22(1), 97–104. https://doi.org/10.1007/s40519-016-0301-9
   PubMed Web of Science ®Google Scholar
• Long, C. G., Rowell, A., Gayton, A., Hodgson, E., & Dolley, O. (2014). Tackling obesity and its complications in secure settings. Mental Health Review Journal, 19(1), 37–46. https://doi.org/10.1108/MHRJ-04-2013-0012
   Google Scholar
• Mat, A., Ahern, T., Hoare, T., McCarran, P., Kennedy, H. G., & O'Shea, D. (2015). The prevalence of obesity and metabolic syndrome among inpatients at a Forensic Psychiatric Hospital in the Republic of Ireland. Endocrine Abstracts, 37(574) https://doi.org/10.1530/endoabs.37.EP574
   Google Scholar
• Meltzer, H. Y., Perry, E., & Jayathilake, K. (2003). Clozapine-induced weight gain predicts improvement in Psychopathology. Schizophrenia Research, 59(1), 19–27. https://doi.org/10.1016/s0920-9964(01)00326-7
   PubMed Web of Science ®Google Scholar
• Mills, S., & Davies, J. L. (2022). Making days count: National review of patients cared for in secure mental health hospitals. The National Collaborative Commissioning Unit. https://nccu.nhs.wales/qais/national-reviews/making-days-count/mdc-documents/making-days-count1/
   Google Scholar
• Ministry of Health. (2020). Annual update of key results 2019/20: New Zealand health survey. https://www.health.govt.nz/publication/annual-update-key-results-2019-20-new-zealand-health-survey
   Google Scholar
• Murashita, M., Kusumi, I., Inoue, T., Takahashi, Y., Hosoda, H., Kangawa, K., & Koyama, T. (2005). Olanzapine increases plasma ghrelin level in patients with schizophrenia. Psychoneuroendocrinology, 30(1), 106–110. https://doi.org/10.1016/j.psyneuen.2004.05.008
   PubMed Web of Science ®Google Scholar
• National Health Service. (2014). Five year forward view. https://www.england.nhs.uk/wp-content/uploads/2014/10/5yfv-web.pdf
   Google Scholar
• National Institute for Health and Care Excellence. (2014). Obesity: Identification, assessment and management [CG189]. https://www.nice.org.uk/guidance/cg189/resources/obesity-identification-assessmentand-management-pdf-35109821097925
   Google Scholar
• Orellana, G., & Slachevsky, A. (2013). Executive functioning in schizophrenia. Frontiers in Psychiatry, 4, Article 35. https://doi.org/10.3389/fpsyt.2013.00035
   Google Scholar
• Pack, S. (2009). Poor physical health and mortality in patients with schizophrenia. Nursing Standard, 23(21), 41–45. https://doi.org/10.7748/ns.23.21.41.s50
   PubMedGoogle Scholar
• Perez-Iglesias, R., Crespo-Facorro, B., Martinez-Garcia, O., Ramirez-Bonilla, M. L., Alvarez-Jimenez, M., Pelayo-Teran, J. M., Garcia-Unzueta, M. T., Amado, J. A., & Vazquez-Barquero, J. L. (2008). Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: Findings of a randomized clinical trial in a drug-naïve population. Schizophrenia Research, 99(1-3), 13–22. https://doi.org/10.1016/j.schres.2007.10.022
   PubMed Web of Science ®Google Scholar
• Public Health England. (2021). Managing a health weight in adult secure services - practice guidance. https://www.england.nhs.uk/wpcontent/uploads/2021/02/B0121_Managing-a-healthy-weight-Adult-Secure-Servicespractice-guidance-090221.pdf
   Google Scholar
• Public Health Wales. (2019). Obesity in Wales report. https://phw.nhs.wales/topics/obesity/obesity-in-wales-report-pdf/
   Google Scholar
• Roche, A. I., Kroska, E. B., Miller, M. L., Kroska, S. K., & O'Hara, M. W. (2019). Childhood trauma and problem behavior: Examining the mediating roles of experiential avoidance and mindfulness processes. Journal of American College Health : J of ACH, 67(1), 17–26. https://doi.org/10.1080/07448481.2018.1455689
   PubMed Web of Science ®Google Scholar
• Rogers, E., Papathomas, A., & Kinnafick, F.-E. (2021). Inpatient perspectives on physical activity in a secure mental health setting. Psychology of Sport and Exercise, 52, 101827. https://doi.org/10.1016/j.psychsport.2020.101827
   Web of Science ®Google Scholar
• Sahpolat, M., & Ari, M. (2021). Higher prevalence of metabolic syndrome and related factors in patients with first-episode psychosis and schizophrenia: A cross-section study in Turkey. Nordic Journal of Psychiatry, 75(1), 73–78. https://doi.org/10.1080/08039488.2020.1815080
   PubMed Web of Science ®Google Scholar
• Sansone, R. A., & Sansone, L. A. (2013). The relationship between borderline personality and obesity. Innovations in Clinical Neuroscience, 10(4), 36–49.
   PubMedGoogle Scholar
• Saunders, K. H., Igel, L. I., Shukla, A. P., & Aronne, L. J. (2016). Drug-induced weight gain: Rethinking our choices. Journal of Family Practice, 65(11), 780–788.
   PubMed Web of Science ®Google Scholar
• Seed, T., Fox, J. R. E., & Berry, K. (2016). The experience of involuntary detention in acute psychiatric care. A review and synthesis of qualitative studies. International Journal of Nursing Studies, 61, 82–94. https://doi.org/10.1016/j.ijnurstu.2016.05.014
   PubMed Web of Science ®Google Scholar
• Shin, J. K., Barron, C. T., Chiu, Y. L., Hyun Jang, S., Touhid, S., & Bang, H. (2012). Weight changes and characteristics of patients associated with weight gain during inpatient psychiatric treatment. Issues in Mental Health Nursing, 33(8), 505–512. https://doi.org/10.3109/01612840.2012.683931
   PubMedGoogle Scholar
• Stewart, C. (2022, December 21). Mean body mass index (BMI) of adults in England 2021, by gender and age. Statista. https://www.statista.com/statistics/375886/adult-s-body-mass-index-by-gender-and-age-in-england/
   Google Scholar
• Subashini, R., Deepa, M., Padmavati, R., Thara, R., & Mohan, V. (2011). Prevalence of diabetes, obesity, and metabolic syndrome in subjects with and without schizophrenia (CURES-104). Journal of Postgraduate Medicine, 57(4), 272–277. https://doi.org/10.4103/0022-3859.90075
   PubMed Web of Science ®Google Scholar
• Sušilová, L., Češková, E., Hampel, D., Sušil, A., & Šimůnek, J. (2017). Changes in BMI in hospitalized patients during treatment with antipsychotics, depending on gender and other factors. International Journal of Psychiatry in Clinical Practice, 21(2), 112–117. https://doi.org/10.1080/13651501.2017.1291818
   PubMed Web of Science ®Google Scholar
• Taylor, D. M., Barnes, T. R. E., & Young, A. H. (2018). The Maudsley prescribing guidelines in psychiatry (13th ed.). John Wiley & Sons.
   Google Scholar
• Tuncer, G. Z., & Çetinkaya Duman, Z. (2020). An examination of emotional eating behavior in individuals with a severe mental disorder. Archives of Psychiatric Nursing, 34(6), 531–536. https://doi.org/10.1016/j.apnu.2020.10.002
   PubMed Web of Science ®Google Scholar
• Welsh Government. (2020). A healthier Wales: our plan for health and social care. (WG42574). https://gov.wales/sites/default/files/publications/2021-09/a-healthier-wales-our-plan-for-health-and-social-care.pdf
   Google Scholar
• Wetterling, T. (2001). Bodyweight gain with atypical antipsychotics. Drug Safety, 24(1), 59–73. https://doi.org/10.2165/00002018-200124010-00005
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2016). International statistical classification of diseases and related health problems (10th ed.). https://icd.who.int/browse10/2016/en
   Google Scholar
• Zareifopoulos, N., Bellou, A., Spiropoulou, A., & Spiropoulos, K. (2018). Prevalence of comorbid chronic obstructive pulmonary disease in individuals suffering from schizophrenia and bipolar disorder: A systematic review. COPD, 15(6), 612–620. https://doi.org/10.1080/15412555.2019.1572730
   PubMedGoogle Scholar
• Zolezzi, M., Abdulrhim, S., Isleem, N., Zahrah, F., & Eltorki, Y. (2017). Medical comorbidities in patients with serious mental illness: A retrospective study of mental health patients attending an outpatient clinic in Qatar. Neuropsychiatric Disease and Treatment, 13, 2411–2418. https://doi.org/10.2147/NDT.S141448
   PubMed Web of Science ®Google Scholar